Abstract
A genome-wide association screen for primary biliary cirrhosis risk alleles was performed in an Italian cohort. The results from the Italian cohort replicated IL12A and IL12RB associations, and a combined meta-analysis using a Canadian dataset identified newly associated loci at SPIB (P = 7.9 × 10−11, odds ratio (OR) = 1.46), IRF5-TNPO3 (P = 2.8 × 10−10, OR = 1.63) and 17q12-21 (P = 1.7 × 10−10, OR = 1.38).
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Single cell sequencing analysis identifies genetics-modulated ORMDL3+ cholangiocytes having higher metabolic effects on primary biliary cholangitis
Journal of Nanobiotechnology Open Access 06 December 2021
-
Regional heritability mapping identifies several novel loci (STAT4, ULK4, and KCNH5) for primary biliary cholangitis in the Japanese population
European Journal of Human Genetics Open Access 09 April 2021
-
rs1944919 on chromosome 11q23.1 and its effector genes COLCA1/COLCA2 confer susceptibility to primary biliary cholangitis
Scientific Reports Open Access 25 February 2021
Access options
Subscribe to this journal
Receive 12 print issues and online access
$189.00 per year
only $15.75 per issue
Rent or buy this article
Get just this article for as long as you need it
$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Gershwin, M.E. & Mackay, I.R. Hepatology 47, 737–745 (2008).
Hirschfield, G.M. et al. N. Engl. J. Med. 360, 2544–2555 (2009).
Invernizzi, P. et al. Hepatology 48, 1906–1912 (2008).
Moffatt, M.F. et al. Nature 448, 470–473 (2007).
McGovern, D.P. et al. Nat. Genet. 42, 332–337 (2010).
Barrett, J.C. et al. Nat. Genet. 41, 703–707 (2009).
Romero, F., Martinez, A.C., Camonis, J. & Rebollo, A. EMBO J. 18, 3419–3430 (1999).
Wang, J.H. et al. Immunity 9, 543–553 (1998).
Sun, J., Matthias, G., Mihatsch, M.J., Georgopoulos, K. & Matthias, P. J. Immunol. 170, 1699–1706 (2003).
Garrett-Sinha, L.A. et al. Immunity 10, 399–408 (1999).
Dontje, W. et al. Blood 107, 2446–2452 (2006).
Nguyen, V.T. & Benveniste, E.N. J. Biol. Chem. 275, 23674–23684 (2000).
Remmers, E.F. et al. N. Engl. J. Med. 357, 977–986 (2007).
Sleiman, P.M. et al. N. Engl. J. Med. 362, 36–44 (2010).
Guo, F., Velu, C.S., Grimes, H.L. & Zheng, Y. Blood 114, 2909–2916 (2009).
Acknowledgements
We thank the subjects and physicians who contributed DNA samples and clinical data for this study. This work was supported in part by the US National Institutes of Health (R01 DK056839, R01 DK80670, K23 DK68290 and RO3 DK78527), the Canadian Institutes for Health Research (MOP 74621), the Ontario Research Fund (RE01-061), the Canadian Primary Biliary Cirrhosis Society, the American Gastroenterological Association and the A.J. and Sigismunda Palumbo Charitable Trust.
Author information
Authors and Affiliations
Contributions
X.L., P.I., Yue Lu and R.K. contributed to initial data analyses and manuscript preparation. P.I., R.S., C.S. and A.L. managed DNA samples. A.L., F. Macciardi, A.T.L. and P.K.G. performed genotyping. M.R. provided database management. P.I., Yan Lu, I.B., M.P., C.X., G.X., A.L.M., R.P.M., K.M.P., C.N.G., F.B., M.Z., E.J.H., S.L., F.R., E.B., A.F., R.L., G.N., A.A., L. Muratori, P.M., P.L.A., P.A., M. Margotti, M.B., B.C., D.A., M.C.B., F. Marra, A. Pisano, C.R., M.C., M. Marzioni, A.B., L.F., M.S., P.P., V.O.P., C.T., L.C., S.B., S.R., M.V., C.P., A.M., P.T., A. Picciotto, A.G., C.F., S.C., G.C., L. Morini, N.C., A.C., G.S. and R.M. contributed to experimental design, subject assessment and sample collection. P.I., G.M.H., K.A.S., C.I.A., M.E.G. and M.F.S. contributed to experimental design and interpretation, statistical analyses, and initial manuscript preparation. All authors contributed to the final paper.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Supplementary information
Supplementary Text and Figures
Supplementary Figures 1 and 2, Supplementary Tables 1–5 and Supplementary Methods (PDF 439 kb)
Rights and permissions
About this article
Cite this article
Liu, X., Invernizzi, P., Lu, Y. et al. Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis. Nat Genet 42, 658–660 (2010). https://doi.org/10.1038/ng.627
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ng.627
This article is cited by
-
Environmental factors, medical and family history, and comorbidities associated with primary biliary cholangitis in Japan: a multicenter case–control study
Journal of Gastroenterology (2022)
-
Single cell sequencing analysis identifies genetics-modulated ORMDL3+ cholangiocytes having higher metabolic effects on primary biliary cholangitis
Journal of Nanobiotechnology (2021)
-
rs1944919 on chromosome 11q23.1 and its effector genes COLCA1/COLCA2 confer susceptibility to primary biliary cholangitis
Scientific Reports (2021)
-
Genome-wide association study of serum liver enzymes implicates diverse metabolic and liver pathology
Nature Communications (2021)
-
Regional heritability mapping identifies several novel loci (STAT4, ULK4, and KCNH5) for primary biliary cholangitis in the Japanese population
European Journal of Human Genetics (2021)
